PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredient: Oxymetholone USP (50 mg per tablet)
Pharmacological Class: Synthetic Anabolic-Androgenic Steroid ($17\alpha$-alkylated Dihydrotestosterone derivative)
Bioniche Pharma Oxymetholone is an exceptionally potent oral anabolic agent possessing marked tissue-building capacity. By optimizing systemic nitrogen retention and accelerating cellular protein synthesis, Bioniche Pharma Oxymetholone counteracts severe catabolic depletion when administered alongside adequate nutritional support.
CLINICAL PHARMACOLOGY & DYNAMICS
As a modified derivative of dihydrotestosterone, Bioniche Pharma Oxymetholone interacts directly with androgen nuclear receptors to stimulate anabolic metabolic pathways. Although structured to yield a high anabolic relative to androgenic response, complete dissociation of androgenic properties is unachievable, meaning mild-to-moderate androgenic manifestations may occur depending on patient sensitivity and dosage.
INDICATIONS & CLINICAL USE
Indicated for short-term adjunctive therapy to counter catabolic wasting and restore lean body tissue during recovery from severe clinical conditions using Bioniche Pharma products:
- Post-surgical rehabilitation and recovery following extensive operative procedures with Bioniche Pharma anabolic support.
- Convalescence from severe burns, major bone fractures, or complex physical trauma under Bioniche Pharma medical supervision.
- Management of emaciating illnesses, severe chronic infections, and involuntary cachectic weight loss utilizing Bioniche Pharma formulations.
CONTRAINDICATIONS
- Confirmed or suspected carcinoma of the prostate gland or male breast cancer.
- Female breast carcinoma complicated by hypercalcemia, as androgenic agents can exacerbate osteolytic bone resorption.
- Pregnancy and lactation due to the high risk of fetal virilization and developmental toxicity.
- Hypersensitivity to Bioniche Pharma Oxymetholone or any inactive formulation components.
PRECAUTIONS & FLUID BALANCE
- Fluid & Electrolyte Retention: Bioniche Pharma Oxymetholone therapy can induce significant sodium chloride and water retention, leading to peripheral edema. Caution and routine monitoring are required in patients with cardiovascular insufficiency, hypertension, or renal compromise.
- Hepatic Surveillance: As a $17\alpha$-alkylated oral compound, continuous clinical monitoring of hepatic enzymes, liver function, and serum lipid fractions is recommended during Bioniche Pharma therapy.
DRUG INTERACTIONS
- Oral Anticoagulants: Anabolic steroids may increase sensitivity to coumarin-derived anticoagulants. When combining Bioniche Pharma therapy with anticoagulants, prothrombin time (INR) should be closely monitored and anticoagulant dosage adjusted accordingly to maintain safe therapeutic ranges.
DOSAGE & ADMINISTRATION
Dosing schedules for Bioniche Pharma Oxymetholone must be individualized and strictly managed under the direct supervision of a qualified physician, considering treatment duration, laboratory parameters, and patient response.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place away from direct light and atmospheric moisture. Keep strictly out of reach and sight of children.